Privilege, business, and obsession: Ariel García Furfaro's days a year after fentanyl arrest
Translated from Spanish, summarized and contextualized by DistantNews.
At a glance
- Ariel García Furfaro, owner of HLB Pharma and Ramallo, faces scrutiny over at least 90 deaths linked to contaminated fentanyl.
- The investigation into the laboratories has led to the arrest and bail of two former ANMAT officials for allegedly covering up company failures.
- The case highlights issues of privilege and business dealings surrounding the pharmaceutical entrepreneur a year after his arrest.
A year after his arrest for contaminated fentanyl, businessman Ariel García Furfaro remains at the center of a scandal involving at least 90 deaths. Furfaro owns HLB Pharma and Ramallo, the laboratories under investigation. This week, judicial authorities arrested and later released two former officials from Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) on bail. They are accused of covering up failures related to the companies' operations.
The case has brought to light allegations of privilege and questionable business practices surrounding Furfaro. The investigation continues to probe the extent of the laboratories' responsibilities in the deaths linked to the contaminated fentanyl, raising serious questions about regulatory oversight and corporate accountability in Argentina.
Originally published by Clarín in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.